Table 4.

Overview of the literature for hepatic metastasectomy for soft tissue sarcoma

Reference	Institution	N	5y OS (%)	Median OS (mo)	Proportion RPS (%)
Harrison 1997 [115]	MSKCC, New York, USA	27	26	31	22
Chen 1998 [116]	Johns Hopkins, Baltimore, USA	11	–	39	45
Lang 2000 [117]	Hannover, Germany	26	20 (after R0-resection)	32 (after R0 resection)	19
DeMatteo 2001 [46]	MSKCC, New York, USA	22	30	39	N/A
Ercolani 2005 [118]	Bologna, Italy	10	36	44	N/A
Yedibela 2005 [119]	Erlangen, Germany	15	–	–	N/A
Adam 2006 [120]	Multi-institutional	125	31	32	N/A
Pawlik 2006 [121]	MDACC, Houston, USA	53	27	47	42 (abdomen/RP)
Rehders 2009 [30]	Dusseldorf, Germany	27	49	44	30 (RS/pelvis)
Marudanayagam 2011 [122]	Birmingham, UK	36	31.8	24	5.5
Groeschl 2012 [123]	Multi-institutional (four centers)	98 (excluding GIST)	32	72	N/A
Brudvik 2015 [26]	MDACC, Houston, USA	47 LMS, 50 other subtypes	48.4 LMS	42.1 LMS	21 (LMS)
			44.9 other subtypes	45.5 other subtypes

GISTs and bone sarcomas were excluded when possible.

OS, overall survival; RPS, retroperitoneal sarcoma; N/A, not available.